Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
Learning to stop smoking is not easy. You cough. You fidget. You crave. All you want is a cigarette. Just one. You want to go back to the day that you started this process and live that day over. But these days, your doctor can offer you a lot more help in the form of smoking cessation drugs. Yes, that’s right, they can even double your chance of quitting. There are just a few caveats, but no biggie. Besides increasing your hostility, agitation, depressed mood and suicidal thoughts, they’ll also elevate your risk for other psychiatric disorders, not to mention bring down your gastrointestinal, metabolic, nervous, endocrine, immunological, renal, respiratory and cardiovascular systems. But hey, at least you’ll quit smoking right?
The side effects from these drugs are so bad that The Food and Drug Administration (FDA) said that medications such as varenicline (Chantix) and bupropion (Zyban and generics) must now carry a “black box” warning that they can dramatically increase the risk of psychological side effects including serious neuropsychiatric symptoms such as serious suicidal thoughts which lead to attempted suicide.
Some side effects are so serious that they can easily be considered as more of a hazard to long-term health than smoking itself, especially due to the amount of body systems involved and the severity of psychiatric symptoms affected.
The “black box” warning means that the makers of these drugs must list side effects in any advertising and will not be able to air “reminder ads,” which highlight a drug’s name but don’t mention the condition it treats. The warning won’t have an effect on “help-seeking ads,” which mention a condition, but not drug names–like the one dissected in the AdWatch video below.
ADDITIONAL SIDE EFFECTS
Gastrointestinal
Gastrointestinal (GI) side effects have frequently included nausea (7.2% to 40%), flatulence (6% to 9%), constipation (5% to 8.5%), upper abdominal pain (2% to 7.7%), dry mouth (4% to 6%), abdominal pain (5%), dyspepsia (5%), vomiting (1% to 5%), and GI reflux disease (1%). Diarrhea, gingivitis, dysphagia, enterocolitis, eructation, gastritis, GI hemorrhage, mouth ulceration, esophagitis, gastric ulcer, intestinal obstruction, acute pancreatitis, and gall bladder disease have been reported. At least one case of cholecystitis has also been reported, in addition to case of peritonitis and a case of hemorrhoids and rectal prolapse.
The most common side effect associated with varenicline in clinical trials was nausea. Nausea was typically transient and described as mild or moderate in intensity; however, some patients experienced persistent nausea throughout treatment.
Be AWARE truthisscary.com